AIM
AGN

abrdn Investment Management’s Allergan plc AGN Stock Holding History

abrdn Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$45M Buy
184,974
+62,506
+51% +$14.7M 0.15% 122
2017
Q1 		$29.3M Buy
+122,468
New +$28.5M 0.1% 136
2015
Q1 		– Sell
-4,797
Closed -$1.24M – 457
2014
Q4 		$1.24M Sell
4,797
-6,254
-57% -$1.56M ﹤0.01% 235
2014
Q3 		$2.67M Buy
11,051
+3,643
+49% +$815K 0.01% 208
2014
Q2 		$1.65M Buy
+7,408
New +$1.53M 0.01% 238
2013
Q3 		– Sell
-5,524
Closed -$697K – 546
2013
Q2 		$697K Buy
+5,524
New +$625K ﹤0.01% 289

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

abrdn Investment Management's AGN Position: Q2 2017 in Review

abrdn Investment Management increased its Allergan plc (AGN) stake by 51% in Q2 2017, buying an estimated $14.7M and bringing the position to 184,974 shares worth $45M. The position accounts for 0.15% of the portfolio, ranked #122.

abrdn Investment Management first reported a position in AGN in Q2 2013 and has held it in 6 quarters since. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • abrdn Investment Management held 184,974 shares of Allergan plc worth $45M as of Q2 2017.
  • abrdn Investment Management bought 62,506 Allergan plc shares in Q2 2017, an estimated $14.7M.
  • Allergan plc made up 0.15% of abrdn Investment Management's portfolio in Q2 2017, its #122 holding.
  • abrdn Investment Management first reported a position in Allergan plc in Q2 2013 and has held it in 6 quarters since.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.